While people’s lives and jobs are being devastated by the coronavirus pandemic (COVID-19), and there has been no FDA-approved treatment, governors or state pharmacy boards in Nevada, Michigan, New York, Ohio, and Texas are issuing emergency orders to restrict which medications doctors can use to save lives.            

These politicians have no background in infectious disease, medicine, research design, or epidemiology, yet they presume to dictate to front-line physicians who are reading the emerging research and caring for patients.            

Many doctors are using older medicines, FDA approved for more than 70 years and widely used worldwide to treat malaria, lupus, and rheumatoid arthritis—chloroquine and hydroxychloroquine (Plaquenil). They often add azithromycin (Z-pak), a commonly used antibiotic with some activity against this virus.            

These politicians are presuming to decide that doctors may not prescribe these drugs “off-label,” i.e. for anything other than the disease for which the FDA originally approved the drug. Their pretext is that we do not have large randomized controlled clinical trials (RCT) for this new indication.            

While we are facing one of the most devastating public health crises in our lifetime, there is NO time to wait for the years-long process of an RCT to provide “proof.” Doctors who use the drugs can observe first-hand how patients respond.            

While governors have been handing down orders, doctors in the U.S. and overseas have been reporting remarkable success in treating COVID-19 patients: reductions in hospitalization, less need for scarce ventilators, less need for ICU and intubations, and significantly lower death rates. Two studies from France, conducted by Dr. Didier Raoult, specialist in infectious disease and viral illness, are very promising. Besides helping relieve signs of illness, hydroxychloroquine plus azithromycin also appears to shorten the period of infectivity, which is critically important in controlling disease spread. Data on safety and effectiveness of hydroxychloroquine and azithromycin are coming in almost daily from more than 10 countries, including Canada, Australia, Israel, South Korea, and China.            

Several Governors jumped on this restriction bandwagon soon after President Trump announced at a recent Corona Task Force briefing that chloroquine and hydroxychloroquine showed hope in treating COVID-19, based on several small clinical studies from Johns Hopkins, France, and (at last count) eight other countries. He did not say he recommended these medicines, as some media have falsely stated.            

After 70 years of experience, physicians are well-acquainted with potential side effects, and are aware of patients who should not take them. On the whole, they are quite safe. Dr. Vladimir Zelenko, a board-certified family physician in a small community in New York state hard hit with coronavirus infections, has been successfully using the combination of hydroxychloroquine, azithromycin, zinc and vitamin C to treat almost 700 patients in the outpatient setting. His results are remarkable: zero deaths, zero intubations/ventilators needed, and only four patients hospitalized due to pneumonia. This protocol has been effective in several countries to decrease hospitalizations, and reduce the duration of viral shedding that is a risk to other people.           

Yet Governor Cuomo’s emergency order restricted this treatment to only hospitalized patients, and only those in a New York approved clinical trial. Such a rigid restriction of FDA-approved medicines being used off label to help patients stay out of the hospital makes no sense. Why is a politician making arbitrary medical edicts?

Those who are afraid of “off-label” use need to know that physicians use medications in this way constantly. Until this crisis, there has been no outcry about doctors using old medicines for new uses. This freedom has allowed more rapid discovery of life-saving treatments. Here are a few of many possible examples:

  • Amitriptyline (Elavil®), first approved for depression, is now used for nerve pain.
  • Trazodone, approved for depression, is widely used at lower doses for sleep.
  • Sildenafil (Viagra®), approved for erectile dysfunction, is also used to treat pulmonary artery hypertension.
  • The anti-parasite medicines nifurtimox and eflornithine were successfully used off label to treat children with the rare, fatal brain cancer neuroblastoma.

The United States FDA on Sunday March 28, 2020 issued an Emergency Use Authorization (EUA) for hydroxychloroquine and chloroquine to be used as approved treatments for COVID 19. This EUA illustrates my point: Governors should NOT be jumping into medical decision-making on limited data and with no medical training, especially at a time of a National Emergency and pandemic when medical information is changing rapidly, and to save lives we must use the tools we have at hand, as safely as possible in a war against an invisible enemy.   

Physicians take the Oath of Hippocrates to use their best medical judgement to prescribe treatments for the benefit of their patients to the best of their ability and above all to “Do no harm.” 

Can Governors who are restricting physicians’ prescription decisions in the COVID 19 pandemic truthfully say the same?

You May Also Like

Vander Hart: Xavier Bacerra Is The Worst Choice for HHS

President-Elect Joe Biden’s appointment of Xavier Bacerra to head Health and Human Services is an insult to anyone who cares about religious liberty.

HHS Adopts Conscience Protections for Healthcare Workers

The U.S. Department of Health and Human Services adopted a rule enforcing federal law that protects the conscience rights of healthcare workers.

Grassley Sworn In As Senate President Pro Tempore

U.S. Senator Chuck Grassley (R-Iowa) was sworn in as Senate President Pro Tempore for the 116th Congress and is now third in line of presidential succession.

2019: A Year of Historic Judicial Confirmations

In 2019, the Senate confirmed a historic 102 judges, further solidifying President Trump’s legacy in reshaping the federal judiciary.